跳至主要内容
临床试验/ISRCTN07413772
ISRCTN07413772已完成未知

The role of intensive insulin therapy in critically ill medical and surgical patients

King Fahad National Guard Hospital (Saudi Arabia)0 个研究点目标入组 522 人开始时间: 2005年7月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
522

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adults (greater than 18 years old) able to give consent (directly or via proxy)
  • 2. Random admission blood glucose level greater than 6.1 mM/l (greater than 110 mg/dl)

排除标准

  • 1. Type I diabetes
  • 2. Patients admitted with diabetic ketoacidosis
  • 3. Patients with terminal illness (survival judged by the treating physician less than four weeks)
  • 4. Patients with do not resuscitate (DNR) orders
  • 5. Pregnancy
  • 6. Patients with expected intensive care unit (ICU) length of stay (LOS) of less than 24 hours
  • 7. History of hypoglycaemia during the same hospitalisation
  • 8. Seizure disorder (known active in the last 6 months)
  • 9. Post-cardiac arrest patients
  • 10. Readmission to ICU within the same hospitalisation
  • 11. Brain death
  • 12. Liver transplant
  • 13. Enrolled in another competing study
  • 14. Refused consent
  • 15. No consent within 24 hours of meeting inclusion criteria
  • 16. Other reasons

研究者

发起方
King Fahad National Guard Hospital (Saudi Arabia)

相似试验

The role of intensive insulin therapy in critically... | 临床试验